← Back to Search

Other

Vagal Nerve Stimulation for POTS

N/A
Recruiting
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-80 years old, female or male
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 minute
Awards & highlights

Study Summary

This trial will test if an autoimmune reaction is the cause of symptoms in some patients with POTS, and if electrical stimulation of the vagus nerve can help.

Who is the study for?
This trial is for adults aged 18-80 with Postural Tachycardia Syndrome (POTS), characterized by a rapid heartbeat upon standing, without other causes of orthostatic tachycardia. Healthy controls must be non-smoking and not on chronic medications. Excluded are those with recent heart attacks, significant immune or blood disorders, pregnancy, pacemakers or cochlear implants, severe hypertension, history of vagotomy.Check my eligibility
What is being tested?
The study aims to see if stimulating the vagus nerve can improve symptoms in POTS patients by potentially reducing autoimmune reactions and inflammation. Participants will receive either actual vagal stimulation or sham (fake) stimulation to compare effects.See study design
What are the potential side effects?
While specific side effects aren't listed here, generally speaking, vagal stimulation might cause discomfort at the site of stimulation, changes in voice tone due to laryngeal muscle activation and possible temporary changes in heart rate.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 80 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 minute
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 minute for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Heart rate variability

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Vagal stimulationActive Control1 Intervention
Vagal stimulation will be given at 20 Hz for 1 hour daily with the bipolar electrode attached to the tragus for 2 months.
Group II: Sham stimulationPlacebo Group1 Intervention
Sham stimulation will be given at 20 Hz for 1 hour daily with the bipolar electrode attached to the earlobe for 2 months.

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
456 Previous Clinical Trials
95,575 Total Patients Enrolled
2 Trials studying Postural Orthostatic Tachycardia Syndrome
63 Patients Enrolled for Postural Orthostatic Tachycardia Syndrome
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,852 Previous Clinical Trials
47,817,458 Total Patients Enrolled
11 Trials studying Postural Orthostatic Tachycardia Syndrome
760 Patients Enrolled for Postural Orthostatic Tachycardia Syndrome
Stavros Stavrakis, MDStudy DirectorUniversity of Oklahoma
6 Previous Clinical Trials
274 Total Patients Enrolled
1 Trials studying Postural Orthostatic Tachycardia Syndrome
5 Patients Enrolled for Postural Orthostatic Tachycardia Syndrome

Media Library

Vagal stimulation (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05043051 — N/A
Postural Orthostatic Tachycardia Syndrome Research Study Groups: Vagal stimulation, Sham stimulation
Postural Orthostatic Tachycardia Syndrome Clinical Trial 2023: Vagal stimulation Highlights & Side Effects. Trial Name: NCT05043051 — N/A
Vagal stimulation (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05043051 — N/A
Postural Orthostatic Tachycardia Syndrome Patient Testimony for trial: Trial Name: NCT05043051 — N/A
~17 spots leftby Feb 2025